Subsequently, rabbits were immunized with recombinant proteins and then purified polyclonal antibodies were used for assessment of their inhibitory effects on HER2/HER3 expressing tumor cell lines (BT-474 and JIM-T1). The gene discussed is ERBB3; the disease is neoplasm.